Published in Stroke on September 04, 2008
Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord (2013) 0.97
Characterisation of genome-wide association epistasis signals for serum uric acid in human population isolates. PLoS One (2011) 0.89
Higher baseline serum uric acid is associated with poorer cognition but not rates of cognitive decline in women. Exp Gerontol (2014) 0.81
Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol (2011) 0.80
Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age (Dordr) (2016) 0.80
Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. Cancer Epidemiol Biomarkers Prev (2016) 0.79
Postmortem brain levels of urate and precursors in Parkinson's disease and related disorders. Neurodegener Dis (2013) 0.78
GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans. BMC Genomics (2016) 0.75
Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults. J Alzheimers Dis (2016) 0.75
Low uric acid is a risk factor in mild cognitive impairment. Neuropsychiatr Dis Treat (2017) 0.75
Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling? J Inherit Metab Dis (2015) 0.75
Potential contribution of the neurodegenerative disorders risk loci to cognitive performance in an elderly male gout population. Medicine (Baltimore) (2017) 0.75
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med (1990) 5.91
Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults. Neuropsychology (2007) 2.30
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) (2004) 2.13
Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke (2007) 1.49
Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord (1998) 1.40
Serum uric acid and brain ischemia in normal elderly adults. Neurology (2007) 1.39
Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology (2007) 1.33
Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke (1998) 1.26
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med (2005) 1.15
Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol (2005) 1.14
Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. J Lipid Res (2002) 1.13
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet (1999) 4.06
Attenuated variants of Lesch-Nyhan disease. Brain (2010) 2.80
Delineation of the motor disorder of Lesch-Nyhan disease. Brain (2006) 2.30
Environmental neurotoxin-induced progressive model of parkinsonism in rats. Ann Neurol (2010) 2.17
Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology (2006) 2.15
The functional neuroanatomy of dystonia. Neurobiol Dis (2011) 2.08
Electrocorticographic high gamma activity versus electrical cortical stimulation mapping of naming. Brain (2005) 2.06
The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain (2008) 1.82
Lesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev (2000) 1.71
Neuropathology of cervical dystonia. Exp Neurol (2012) 1.69
Abnormal cerebellar signaling induces dystonia in mice. J Neurosci (2002) 1.67
Source-based morphometry: the use of independent component analysis to identify gray matter differences with application to schizophrenia. Hum Brain Mapp (2009) 1.57
Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study. Lancet Neurol (2013) 1.55
Transcranial direct current stimulation (tDCS) in a realistic head model. Neuroimage (2010) 1.54
Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma (2006) 1.52
Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study. Biol Psychiatry (2005) 1.50
Reproducibility of tDCS Results in a Randomized Trial: Failure to Replicate Findings of tDCS-Induced Enhancement of Verbal Fluency. Cogn Behav Neurol (2016) 1.47
Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery (2004) 1.47
Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.43
Serum uric acid and brain ischemia in normal elderly adults. Neurology (2007) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum? Neurology (2006) 1.37
Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry (2013) 1.35
Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology (2007) 1.33
Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg (2008) 1.31
Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage (2011) 1.30
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology (2007) 1.30
Behavioral aspects of Lesch-Nyhan disease and its variants. Dev Med Child Neurol (2005) 1.29
A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr Res (2008) 1.28
Frequency and bases of abnormal performance by healthy adults on neuropsychological testing. J Int Neuropsychol Soc (2008) 1.18
Dystonia rating scales: critique and recommendations. Mov Disord (2013) 1.17
Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain (2013) 1.17
Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants. Curr Rheumatol Rep (2012) 1.16
Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency. J Int Neuropsychol Soc (2001) 1.15
Extreme task specificity in writer's cramp. Mov Disord (2011) 1.15
HPRT deficiency coordinately dysregulates canonical Wnt and presenilin-1 signaling: a neuro-developmental regulatory role for a housekeeping gene? PLoS One (2011) 1.15
Consequences of impaired purine recycling in dopaminergic neurons. Neuroscience (2008) 1.14
Speech acquisition in older nonverbal individuals with autism: a review of features, methods, and prognosis. Cogn Behav Neurol (2009) 1.11
Optimizing parameters for terminating cortical afterdischarges with pulse stimulation. Epilepsia (2002) 1.11
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1989) 1.11
The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc (2009) 1.10
Schizophrenia and epilepsy: is there a shared susceptibility? Neurosci Res (2009) 1.09
Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. J Int Neuropsychol Soc (2010) 1.09
Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys (2002) 1.08
Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis. Hum Mol Genet (2009) 1.07
Basal ganglia dopamine loss due to defect in purine recycling. Neurobiol Dis (2007) 1.06
Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering. Pharmacol Biochem Behav (2002) 1.06
Outcomes of early delirium diagnosis after general anesthesia in the elderly. Anesth Analg (2013) 1.05
Animal models of generalized dystonia. NeuroRx (2005) 1.04
Positron emission tomography of striatal serotonin transporters in Parkinson disease. Arch Neurol (2003) 1.04
White matter abnormalities and cognition in a community sample. Arch Clin Neuropsychol (2009) 1.04
Selective and sustained α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation in cerebellum induces dystonia in mice. J Pharmacol Exp Ther (2011) 1.04
Abnormal motor behavior and vestibular dysfunction in the stargazer mouse mutant. Neuroscience (2004) 1.03
Self-injurious behavior: gene-brain-behavior relationships. Ment Retard Dev Disabil Res Rev (2001) 1.03
Alzheimer risk variant CLU and brain function during aging. Biol Psychiatry (2012) 1.02
Target optimization in transcranial direct current stimulation. Front Psychiatry (2012) 1.02
Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum (2009) 1.02
A human neuronal tissue culture model for Lesch-Nyhan disease. J Neurochem (2007) 1.01
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res (2007) 1.01
Sleep fragmentation and motor restlessness in a Drosophila model of Restless Legs Syndrome. Curr Biol (2012) 1.01
Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2. J Neurosci (1992) 0.99
Paroxysmal dyskinesias in mice. Mov Disord (2008) 0.99
Keeping your head on target. J Neurosci (2013) 0.98
Irregularity distinguishes limb tremor in cervical dystonia from essential tremor. J Neurol Neurosurg Psychiatry (2007) 0.98
Aggression after traumatic brain injury: prevalence and correlates. J Neuropsychiatry Clin Neurosci (2009) 0.97
Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis (2012) 0.97
Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease. Neurosci Lett (2012) 0.97
Accounting for estimated IQ in neuropsychological test performance with regression-based techniques. J Int Neuropsychol Soc (2009) 0.97
Gray-matter abnormalities in deficit schizophrenia. Schizophr Res (2010) 0.96
Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes. Mov Disord (2013) 0.96
Personalized chemotherapy profiling using cancer cell lines from selectable mice. Clin Cancer Res (2013) 0.96
Sudden death in Lesch-Nyhan disease. Dev Med Child Neurol (2006) 0.96
Development, psychometric properties, and validity of the hopkins adult reading test (HART). Clin Neuropsychol (2009) 0.95
A Golgi study of neuronal architecture in a genetic mouse model for Lesch-Nyhan disease. Neurobiol Dis (2005) 0.95
New semantic learning and generalization in a patient with amnesia. Neuropsychology (2005) 0.95
Genotype-phenotype correlations in Lesch-Nyhan disease: moving beyond the gene. J Biol Chem (2011) 0.95
Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. Schizophr Bull (2013) 0.94
Lesch-Nyhan disease in a female with a clinically normal monozygotic twin. Mol Genet Metab (2005) 0.94
Magnetic resonance imaging at 1.5 T after cochlear implantation. Otol Neurotol (2010) 0.94
Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA. Neurobiol Dis (2001) 0.94
Sex differences in cognition in healthy elderly individuals. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2012) 0.93
Temporal sequence of hemispheric network activation during semantic processing: a functional network connectivity analysis. Brain Cogn (2009) 0.93
Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol (2009) 0.92
Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron (1991) 0.91
Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Res Dev Brain Res (2002) 0.90
Craniocerebral magnetic resonance imaging measurement and findings in Lesch-Nyhan syndrome. Arch Neurol (1998) 0.89
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease. J Clin Pharmacol (2009) 0.89
Cortical auditory dysfunction in benign rolandic epilepsy. Epilepsia (2008) 0.89
Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling. J Neurochem (2013) 0.88
Predictors of new-onset depression after mild traumatic brain injury. J Neuropsychiatry Clin Neurosci (2010) 0.88